Page last updated: 2024-09-04

hyoscyamine and n-methylscopolamine

hyoscyamine has been researched along with n-methylscopolamine in 1 studies

Compound Research Comparison

Studies
(hyoscyamine)
Trials
(hyoscyamine)
Recent Studies (post-2010)
(hyoscyamine)
Studies
(n-methylscopolamine)
Trials
(n-methylscopolamine)
Recent Studies (post-2010) (n-methylscopolamine)
991551,0261252

Protein Interaction Comparison

ProteinTaxonomyhyoscyamine (IC50)n-methylscopolamine (IC50)
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.335
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.0023
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.0023
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0018
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.0011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bermudez, M; Holzgrabe, U; Klöckner, J; Kostenis, E; Mohr, K; Schmitz, J; Schrage, R; Tränkle, C; van der Mey, D; Wolber, G1

Other Studies

1 other study(ies) available for hyoscyamine and n-methylscopolamine

ArticleYear
Dualsteric muscarinic antagonists--orthosteric binding pose controls allosteric subtype selectivity.
    Journal of medicinal chemistry, 2014, Aug-14, Volume: 57, Issue:15

    Topics: Allosteric Regulation; Animals; Atropine Derivatives; Binding Sites; CHO Cells; Cricetulus; Drug Inverse Agonism; Humans; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Muscarinic Agonists; Muscarinic Antagonists; Mutation; Naphthalimides; Phthalimides; Radioligand Assay; Receptor, Muscarinic M2; Scopolamine Derivatives; Stereoisomerism; Structure-Activity Relationship

2014